Literature DB >> 25994610

Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus.

Clarissa Pozzi1, Giuseppe Lofano1, Francesca Mancini1, Elisabetta Soldaini1, Pietro Speziale2, Ennio De Gregorio1, Rino Rappuoli1, Sylvie Bertholet1, Guido Grandi1, Fabio Bagnoli3.   

Abstract

Lack of known mechanisms of protection against Staphylococcus aureus in humans is hindering development of efficacious vaccines. Preclinical as well as clinical data suggest that antibodies play an important role against S. aureus. For instance, certain hypogammaglobulinaemic patients are at increased risk of staphylococcal infections. However, development of effective humoral response may be dampened by converging immune-evasion mechanisms of S. aureus. We hypothesize that B-cell proliferation induced by staphylococcal protein A (SpA) and continuous antigen exposure, without the proper T-cell help and cytokine stimuli, leads to antigen-activated B-cell deletion and anergy. Recent findings suggest an important role of type I neutrophils (PMN-I) and conventionally activated macrophages (M1) against S. aureus, while alternatively activated macrophages (M2) favour biofilm persistence and sepsis. In addition, neutrophil-macrophage cooperation promotes extravasation and activation of neutrophils as well as clearance of bacteria ensnared in neutrophil extracellular traps. Activation of these processes is modulated by cytokines and T cells. Indeed, low CD4(+) T-cell counts represent an important risk factor for skin infections and bacteraemia in patients. Altogether, these observations could lead to the identification of predictive correlates of protection and ways for shifting the balance of the response to the benefit of the host through vaccination. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B cells; Staphylococcus aureus; T cells; correlates of protection; hypogammaglobulinaemia; macrophages; neutrophils; vaccine

Mesh:

Year:  2015        PMID: 25994610     DOI: 10.1093/femsre/fuv024

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  20 in total

1.  Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines.

Authors:  Fabio Bagnoli
Journal:  Virulence       Date:  2017-03-07       Impact factor: 5.882

2.  Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.

Authors:  Assaf Raz; Anna Serrano; Christine Lawson; Maneesha Thaker; Tricia Alston; Stylianos Bournazos; Jeffrey V Ravetch; Vincent A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-20       Impact factor: 11.205

3.  Human Organotypic Models for Anti-infective Research.

Authors:  Astrid Hendriks; Ana Rita Cruz; Elisabetta Soldaini; Andrea Guido Oreste Manetti; Fabio Bagnoli
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

4.  Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.

Authors:  Melissa J Karau; Mulualem E Tilahun; Ashton Krogman; Barbara A Osborne; Richard A Goldsby; Chella S David; Jayawant N Mandrekar; Robin Patel; Govindarajan Rajagopalan
Journal:  Virulence       Date:  2016-12-07       Impact factor: 5.882

5.  Staphylococcus aureus Survives in Cystic Fibrosis Macrophages, Forming a Reservoir for Chronic Pneumonia.

Authors:  Cao Li; Yuqing Wu; Andrea Riehle; Jie Ma; Markus Kamler; Erich Gulbins; Heike Grassmé
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

6.  Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair.

Authors:  Brett A Shook; Renee R Wasko; Omer Mano; Michael Rutenberg-Schoenberg; Michael C Rudolph; Bahar Zirak; Guillermo C Rivera-Gonzalez; Francesc López-Giráldez; Simona Zarini; Amélie Rezza; Damon A Clark; Michael Rendl; Michael D Rosenblum; Mark B Gerstein; Valerie Horsley
Journal:  Cell Stem Cell       Date:  2020-04-16       Impact factor: 24.633

Review 7.  Prevention and treatment of Staphylococcus aureus biofilms.

Authors:  Mohini Bhattacharya; Daniel J Wozniak; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Expert Rev Anti Infect Ther       Date:  2015-11-13       Impact factor: 5.091

8.  Probiotic Exopolysaccharide Protects against Systemic Staphylococcus aureus Infection, Inducing Dual-Functioning Macrophages That Restrict Bacterial Growth and Limit Inflammation.

Authors:  Wonbeom Paik; Francis Alonzo; Katherine L Knight
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

9.  Staphylococcal Protein A Induces Leukocyte Necrosis by Complexing with Human Immunoglobulins.

Authors:  Rachel M McLoughlin; Fabio Bagnoli; Proinnsias G Fox; Francesca Schiavetti; Rino Rappuoli
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

10.  Staphylococcal Protein A Promotes Colonization and Immune Evasion of the Epidemic Healthcare-Associated MRSA ST239.

Authors:  Xufen Hong; Juanxiu Qin; Tianming Li; Yingxin Dai; Yanan Wang; Qian Liu; Lei He; Huiying Lu; Qianqian Gao; Yong Lin; Min Li
Journal:  Front Microbiol       Date:  2016-06-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.